Status:
ACTIVE_NOT_RECRUITING
Vaginal Flora for Treatment of Bacterial Vaginosis
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Recurrent Bacterial Vaginitis
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Bacterial vaginosis (BV) is the most common vaginal infection in women. It is caused by a vaginal bacterial imbalance. Treatment with antibiotics is the standard of care but there is a high rate of re...
Eligibility Criteria
Inclusion
- recurrent BV (4 or more incidences in the past year)
- recurrence of BV in less than 2 months of antibiotic treatment or need for prophylactic antibiotic
- 3/4 Amsel criteria and Nugent criteria greater or equal to 7
Exclusion
- pregnancy or planned pregnancy during the study period
- other known diseases
- carriers of Hep B and C
- HIV or syphilis positive
Key Trial Info
Start Date :
June 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02236429
Start Date
June 1 2015
End Date
March 1 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel